4//SEC Filing
HANLY ANN M. 4
Accession 0001209191-22-012955
CIK 0001706431other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:33 PM ET
Size
8.1 KB
Accession
0001209191-22-012955
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Award
Common Stock
2022-02-22+53,500→ 84,100 total - Award
Stock Option (Right to Buy)
2022-02-22+47,000→ 47,000 totalExercise: $29.48Exp: 2032-02-21→ Common Stock (47,000 underlying)
Holdings
- 11.52(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.
- [F3]25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001854528
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 9:33 PM ET
- Size
- 8.1 KB